Tag: warning letters
FDA Warns Companies for Illegally Selling Food & Bev Products Containing CBD
Silver Spring, MD—The latest series of warning letters from the U.S. Food and Drug Administration (FDA) were sent to five companies that FDA said...
NPA Withdraws FDA Lawsuit, Market Stabilization
Washington, D.C.–The Natural Products Association has dropped its lawsuit against the Food and Drug Administration for N-Acetyl-Cysteine (NAC) following guidance issued last month and...
NPA to Host Educational GMP Webinar
Washington, D.C.—On Tuesday, October 11, the Natural Products Association (NPA) will present its interactive and educational webinar on Good Manufacturing Practices (cGMPs) regarding identity....
Weekly News Briefs: New Chapter, NJ Labs, and More
NJ Labs reports on FDA warning letters
NJ Labs reported FDA warning letters that will be issued to companies that have failed to validate that their...
NPA: Study on Adulterated Supplements “Reaffirms FDA’s Performance Failures Gaps”
Washington, D.C.—As WholeFoods Magazine has reported, a new report published in the Journal of the American Medical Association (JAMA; vol. 328, no. 4) suggests...
Study Points to FDA Shortcomings in Policing Adulterated Supplements
Washington, D.C.—FDA warning letters are falling short when it comes to deterring bad actors from selling dietary supplements adulterated with novel and unapproved stimulants...
4 Kratom Companies Sent FDA Warning Letters
Silver Spring, MD—On June 30, 2022, the Food and Drug Administration (FDA) issued warning letters, jointly with the Federal Trade Commission (FTC), to four...
FDA Retracts Warning Letter to Glanbia Performance Nutrition
Silver Spring, MD—On May 9, 2022, the Food and Drug Administration (FDA) announced that it had issued warning letters to 11 companies for selling adulterated...
FDA Warns Companies on Adulterated Dietary Supplements
Update (May 10, 2022, 3:20 pm ET): FDA's original announcement on May 9, 2022, as reported in an earlier version of this article, listed Glanbia Performance...
FDA Sends Warning Letters to CBD, Delta-8 THC Companies
Washington, D.C.—The U.S. Food and Drug Administration (FDA) announced that it has issued warning letters to five companies for selling products labeled as containing...
